Format

Send to

Choose Destination
Diabetes Metab Syndr Obes. 2015 Feb 4;8:89-96. doi: 10.2147/DMSO.S78877. eCollection 2015.

Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins.

Author information

1
Scientific Department, Velleja Research, Milan, Italy.
2
ASL TO1, Turin, Italy.
3
AIOR, Pontenure, Province of Piacenza, Italy.
4
University Hospital San Gerardo, Monza, Italy.

Abstract

BACKGROUND:

Statin intolerance is a medical condition often leading patients to nonadherence to the prescribed therapy or to a relevant reduction of the statin dosage. Both situations determine a totally or partially uncontrolled lipid profile, and these conditions unquestionably increase the risk of cardiovascular events.

METHODS:

We enrolled hypercholesterolemic, type 2 diabetic patients complaining of intolerance to statins. Some of them had reduced the statin dose 'until the disappearance of symptoms'; others had opted for treatment with ezetimibe; and yet others were not undergoing any treatment at all. All patients of the three groups were then given a fixed combination of berberine and silymarin (Berberol(®)), known from previous papers to be able to control both lipidic and glycemic profiles.

RESULTS:

The tested product both as a single therapy and as add-on therapy to low-dose statin or to ezetimibe reduced triglycerides, low-density lipoprotein cholesterol, fasting blood glucose, and glycosylated hemoglobin in a significant manner without inducing toxicity conditions that might be somehow ascribed to a statin-intolerant condition.

CONCLUSION:

Our study demonstrates that use of Berberol(®), administered as a single or add-on therapy in statin-intolerant subjects affected by diabetes and hypercholesterolemia is a safe and effective tool capable of improving the patients' lipidic and glycemic profiles.

KEYWORDS:

Berberol®; berberine; cholesterol; ezetimibe; silymarin; type 2 diabetes

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center